Nutricircle (530219)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹274.95 |
| Market Cap | ₹289.42 Cr |
| P/E Ratio | 413.71 |
| ROCE | 3.1% |
| ROE | -21.64% |
| Dividend Yield | 0% |
| Profit Growth | 263.64% |
| Debt/Equity | — |
| Sales Growth | 279.45% |
| 52-Week Range | ₹156.45 — ₹411.4 |
| Sector | Food Products |
Strengths
- Revenue growth of 279.45% signals strong recent demand traction from a small base.
- Profit growth of 263.64% and Piotroski F-Score of 7/9 suggest improving operational health.
- ROCE is positive at 3.10%, indicating the company is generating some operating return on capital.
- Small market cap of ₹289 Cr offers scale potential if the business can sustain profitability.
Concerns
- P/E of 413.71 with latest quarterly net profit of ₹0 Cr implies valuation is pricing in distant future earnings.
- ROE is deeply negative at -21.64%, indicating shareholder capital is being eroded.
- No dividend yield (0.00%), so minority investors get no cash return while waiting.
- Key data gaps—no book value, debt/equity, or promoter holding—make thorough due diligence impossible.
AI Analysis
At ₹274.95, this is exactly the kind of small, superficially exciting business that tests discipline. Nutricircle's market cap is ₹289 Cr, but paying 413.71 times trailing earnings is no bargain. The latest quarter tells the real story: sales of only ₹6 Cr and net profit of ₹0 Cr. That means 279.45% sales growth and 263.64% profit growth are arithmetic illusions from a low, possibly unstable base. As Graham said, price is what you pay, value is what you get; here, value appears thin. Return on equity is negative at -21.64%, so the business is destroying shareholder capital, not compounding it. ROCE of just 3.10% offers little evidence of a durable moat; capital employed could likely earn more in a bank fixed deposit. The Piotroski F-Score of 7/9 is mildly encouraging, but it cannot override a P/E of 413 and zero reported quarterly profit. With no dividend yield, the investor receives zero cash while waiting for uncertain growth. Promoter holding is not disclosed, so I cannot judge whether insiders are aligned with me. This is not a business I can value with confidence. Extraordinary growth rates mean nothing if revenue cannot be converted into owner earnings. In Buffett's terms, this is a good story, not yet a good business. I would wait for a far lower price, or for consistent profitability and improving return on capital, before considering an investment.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer